association id |
FEATURE |
Drug id |
Propr |
Public |
Drug Name |
Drug Target |
N FEATURE pos |
N FEATURE neg |
log max Conc tested |
FEATURE neg logIC50 MEAN |
FEATURE pos logIC50 MEAN |
FEATURE deltaMEAN IC50 |
FEATURE IC50 effectSize |
FEATURE neg Glass delta |
FEATURE pos Glass delta |
ANOVA FEATURE pval |
Tissue ANOVA pval |
MSI ANOVA pval |
ANOVA FEATURE FDR % |
a12 |
BRAF_mut |
1242 |
1 |
1 |
(5Z)-7-Oxozeaenol |
MAP3K7 (TAK1) |
79 |
834 |
2.3 |
0.992 |
-0.879 |
-1.87 |
1.4 * |
1.5 * |
0.98 . |
7.4e-11 |
7.5e-47 |
6.06e-01 |
1e-04 |
a50 |
TP53_mut |
1242 |
1 |
1 |
(5Z)-7-Oxozeaenol |
MAP3K7 (TAK1) |
602 |
311 |
2.3 |
0.32 |
1.09 |
0.774 |
0.56 . |
0.51 . |
0.59 . |
4.19e-07 |
6.57e-46 |
6.09e-01 |
0.14 |
a193 |
loss_cnaPANCAN369 |
1242 |
1 |
1 |
(5Z)-7-Oxozeaenol |
MAP3K7 (TAK1) |
115 |
798 |
2.3 |
0.734 |
1.49 |
0.76 |
0.54 . |
0.54 . |
0.52 . |
7.53e-05 |
2.33e-45 |
6.11e-01 |
6.4 |
a411 |
gain_cnaPANCAN411_(BLM,CRTC3,FANCI,IDH2,NR2F2,PCSK6) |
1242 |
1 |
1 |
(5Z)-7-Oxozeaenol |
MAP3K7 (TAK1) |
25 |
888 |
2.3 |
0.807 |
1.64 |
0.83 |
0.58 . |
0.59 . |
0.46 |
4.93e-04 |
3.65e-45 |
6.12e-01 |
20 |
a449 |
loss_cnaPANCAN261 |
1242 |
1 |
1 |
(5Z)-7-Oxozeaenol |
MAP3K7 (TAK1) |
79 |
834 |
2.3 |
0.773 |
1.43 |
0.655 |
0.46 |
0.46 |
0.51 . |
5.77e-04 |
3.78e-45 |
6.12e-01 |
21 |